arrow
S

Spiros Miyakis

Wollongong Hospital
H指数:28
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management, Outcomes, and Factors Associated With Mortality and Treatment Failure of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand

非曲霉菌霉菌感染的管理、结局及与死亡率和治疗失败相关的因素:一项在澳大利亚和新西兰的多中心研究

2026-08-130
OAAI
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study

针对新型冠状病毒肺炎的改良mRNA-脂质纳米颗粒疫苗候选物的安全性和免疫原性: 1期剂量递增研究的结果

2024-10-180
OAAI
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

MERINO研究中接受哌拉西林/他唑巴坦或美罗培南治疗的患者的最低抑菌浓度,β-内酰胺酶基因与死亡率之间的关联

2020-10-27109
PREAI
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
2018-09-11553
OAAI